Liis Haljasmägi
University of Tartu(EE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Systemic Lupus Erythematosus Research, Long-Term Effects of COVID-19, SARS-CoV-2 detection and testing
Most-Cited Works
- → Autoantibodies against type I IFNs in patients with life-threatening COVID-19(2020)2,815 cited
- → A dynamic COVID-19 immune signature includes associations with poor prognosis(2020)1,025 cited
- → Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study(2021)677 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19(2020)91 cited
- → Monocytes present age‐related changes in phospholipid concentration and decreased energy metabolism(2020)73 cited
- → Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis(2020)68 cited
- → Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data(2020)53 cited
- → A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis(2020)53 cited